These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 240417)

  • 21. Plasmic degradation modulates activity of fibrinogen-bound fibroblast growth factor-2.
    Sahni A; Francis CW
    J Thromb Haemost; 2003 Jun; 1(6):1271-7. PubMed ID: 12871330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen.
    Francis CW; Marder VJ; Martin SE
    J Biol Chem; 1980 Jun; 255(12):5599-604. PubMed ID: 6445903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The alpha(E)C domain of human fibrinogen-420 is a stable and early plasmin cleavage product.
    Applegate D; Steben LS; Hertzberg KM; Grieninger G
    Blood; 2000 Apr; 95(7):2297-303. PubMed ID: 10733499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific identification of fibrin polymers, fibrinogen degradation products, and crosslinked fibrin degradation products in plasma and serum with a new sensitive technique.
    Connaghan DG; Francis CW; Lane DA; Marder VJ
    Blood; 1985 Mar; 65(3):589-97. PubMed ID: 3971042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degradation of human fibrinogen by plasmin: isolation and partial characterization of an early degradation product.
    Regañon E; Aznar J; Vila V
    Haemostasis; 1978; 7(1):26-34. PubMed ID: 147811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmic degradation of human fibrinogen. I. Structural characterization of degradation products.
    Furlan M; Beck EA
    Biochim Biophys Acta; 1972 May; 263(3):631-44. PubMed ID: 4260762
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunologic identification of the cleavage products from the A alpha- and B beta-chains in the early stages of plasmin digestion of fibrinogen.
    Liu CY; Sobel JH; Weitz JI; Kaplan KL; Nossel HL
    Thromb Haemost; 1986 Aug; 56(1):100-6. PubMed ID: 2946092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Terminal plasmin degradation products D and E of duck fibrinogen and their effect on polymerization of fibrin.
    Krajewski T; Nowak P; Cierniewski C
    Acta Biochim Pol; 1985; 32(2):144-54. PubMed ID: 4036448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degradation of cross-linked fibrin by human leukocyte proteases.
    Francis CW; Marder VJ
    J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrin(-ogen) interactions with plasmin.
    Gaffney PJ
    Haemostasis; 1977; 6(1):2-25. PubMed ID: 140113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of plasmic degradation products of human fibrinogen. Fibrinopeptide and polypeptide chain analysis.
    Budzynski AZ; Marder VJ; Shainoff JR
    J Biol Chem; 1974 Apr; 249(7):2294-302. PubMed ID: 4131967
    [No Abstract]   [Full Text] [Related]  

  • 32. Characterization of fibrinogen and fibrin degradation products by isoelectric focusing in polyacrylamide gel.
    Arnesen H
    Thromb Res; 1974 Jun; 4(6):861-8. PubMed ID: 4844064
    [No Abstract]   [Full Text] [Related]  

  • 33. Physicochemical studies on tryptic digestion of bovine fibrinogen.
    Albert A; Regañon E; Saiz JL; Usobiaga P
    Biochim Biophys Acta; 1975 Apr; 386(2):382-90. PubMed ID: 1169967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrin digestion by thrombin. Comparison with plasmin-digested fibrinogen.
    Kang EP; Triantaphyllopoulos DC
    Biochim Biophys Acta; 1977 Feb; 490(2):430-42. PubMed ID: 138448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of soluble fibrinogen-fibrin complex in liquid human plasma; reflexion of coagulation process in storage.
    Abe T; Kazama M; Tahara C; Miura Y; Yasuda J
    Jpn J Med Sci Biol; 1977 Apr; 30(2):91-9. PubMed ID: 916354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the fibrin-polymerizing reaction using sodium dodecylsulfate-agarose gel electrophoresis.
    Moroi M; Inoue N; Yamasaki M
    Biochim Biophys Acta; 1975 Jan; 379(1):217-26. PubMed ID: 1168501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of fragment E from fibrinogen and cross-linked fibrin.
    Slade CL; Pizzo SV; Taylor LM; Steinman HM; McKee PA
    J Biol Chem; 1976 Mar; 251(6):1591-6. PubMed ID: 815259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
    Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
    Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation of fibrinogen and fibrin peptide chains by partial cleavage of disulfide bonds.
    Hörmann H; Wagner HJ
    Hoppe Seylers Z Physiol Chem; 1973 Sep; 354(9):1103-11. PubMed ID: 4807801
    [No Abstract]   [Full Text] [Related]  

  • 40. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.